BENU Vaistinė Lietuva - Company finances
|
EUR
|
2018
From: 2018-02-01
To: 2019-01-31
|
2019
From: 2019-02-01
To: 2020-01-31
|
2020
From: 2020-02-01
To: 2021-01-31
|
2021
From: 2021-02-01
To: 2022-01-31
|
2022
From: 2022-02-01
To: 2023-01-31
|
2023
From: 2023-02-01
To: 2024-01-31
|
2024
From: 2024-02-01
To: 2025-01-31
|
2025
From: 2025-02-01
To: 2026-01-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 52,059,000 | 62,513,000 | 68,273,000 | 76,963,000 | 91,333,000 | 101,430,000 | 112,892,000 | 121,058,000 |
| Profit before tax | 2,182,000 | 2,209,000 | 1,875,000 | 3,120,000 | 2,426,000 | 1,144,000 | 1,871,000 | 953,000 |
| Net profit | - | - | - | - | 2,032,000 | 933,000 | 1,506,000 | 451,000 |
| Equity | 22,324,000 | 23,943,000 | 25,501,000 | 28,176,000 | 24,210,000 | 23,143,000 | 23,649,000 | 23,099,000 |
| Liabilities | - | - | - | - | 46,482,000 | 37,221,000 | 53,176,000 | 43,674,000 |
| Non-current assets | 18,871,000 | 33,773,000 | 33,008,000 | 33,648,000 | 33,361,000 | 32,946,000 | 35,853,000 | 33,212,000 |
| Current assets | 19,118,000 | 23,813,000 | 29,411,000 | 36,995,000 | 37,331,000 | 27,418,000 | 40,972,000 | 33,561,000 |
| Total assets | 37,989,000 | 57,586,000 | 62,419,000 | 70,643,000 | 70,692,000 | 60,364,000 | 76,825,000 | 66,773,000 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,644,628 | 2,658,701 | 2,499,418 |
| Social insurance contributions | - | - | - | - | - | 2,576,363 | 2,591,093 | 2,741,353 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +16.2% | +20.1% | +9.2% | +12.7% | +18.7% | +11.1% | +11.3% | +7.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 2.9% | 1.5% | 2.0% | 0.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 8.4% | 4.0% | 6.4% | 2.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 2.2% | 0.9% | 1.3% | 0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.2% | 3.5% | 2.7% | 4.1% | 2.7% | 1.1% | 1.7% | 0.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.9 | 1.6 | 2.2 | 1.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 125,092 | 143,929 | 158,039 | 182,449 | 211,256 | 231,092 | 278,688 | 311,070 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BENU Vaistinė Lietuva - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-23 | 2024-04-25 | 260.25 |
| 2024-04-16 | 2024-04-22 | 257.91 |
| 2024-03-18 | 2024-03-21 | 751.96 |
| 2024-01-23 | 2024-01-25 | 0.27 |
| 2024-01-16 | 2024-01-22 | 469.93 |
| 2023-10-17 | 2023-10-24 | 373.01 |
| 2023-01-17 | 2023-01-19 | 257.58 |
| 2022-12-16 | 2022-12-21 | 1325.55 |
| 2022-07-18 | 2022-07-20 | 788.78 |
| 2021-11-16 | 2021-11-18 | 133.62 |
BENU Vaistinė Lietuva - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BENU Vaistine Lietuva, UAB (code 135874035) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €121.06M, up 7.2% year on year and 19.4% over two years. Net profit amounted to €451.0K, with a profit margin of 0.4%, showing a clear decline from €1.51M in 2024 and €933.0K in 2023. This indicates that revenue continued to grow, while profitability weakened in 2025. At year-end 2025, total assets stood at €66.77M, equity at €23.10M, and liabilities at €43.67M. The equity ratio was 34.6% and debt-to-equity 1.89, while asset turnover reached 1.81x. Return on equity was 1.9% and return on assets 0.7%, both reflecting modest returns. Revenue per employee was €311.2K, and profit per employee €1.2K, suggesting solid sales productivity but limited bottom-line conversion in 2025.